EGFR c.2294T>G ;(p.V765G)

Variant ID: 7-55248996-T-G

NM_005228.3(EGFR):c.2294T>G;(p.V765G)

This variant was identified in 7 publications

View GRCh38 version.




Publications:


Disruptin, a cell-penetrating peptide degrader of EGFR: Cell-Penetrating Peptide in Cancer Therapy.

Translational Oncology
Mehta, Ranjit K RK; Shukla, Sushmita S; Ramanand, Susmita G SG; Somnay, Vishal V; Bridges, Alexander J AJ; Lawrence, Theodore S TS; Nyati, Mukesh K MK
Publication Date: 2021-08

Variant appearance in text: EGFR: V765G
PubMed Link: 34107419
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Clinical Application of Next-Generation Sequencing of Plasma Cell-Free DNA for Genotyping Untreated Advanced Non-Small Cell Lung Cancer.

Cancers
Fernandes, Maria Gabriela O MGO; Cruz-Martins, Natália N; Souto Moura, Conceição C; Guimarães, Susana S; Pereira Reis, Joana J; Justino, Ana A; Pina, Maria João MJ; Magalhães, Adriana A; Queiroga, Henrique H; Machado, José Carlos JC; Hespanhol, Venceslau V; Costa, José Luis JL
Publication Date: 2021-05-30

Variant appearance in text: EGFR: 2294T>G; V765G
PubMed Link: 34070940
Variant Present in the following documents:
  • Main text
  • cancers-13-02707.pdf
View BVdb publication page



Landscape of drug-resistance mutations in kinase regulatory hotspots.

Briefings In Bioinformatics
Kim, Pora P; Li, Hanyang H; Wang, Junmei J; Zhao, Zhongming Z
Publication Date: 2021-05-20

Variant appearance in text: EGFR: V765G
PubMed Link: 32510566
Variant Present in the following documents:
  • Main text
View BVdb publication page



Finding driver mutations in cancer: Elucidating the role of background mutational processes.

Plos Computational Biology
Brown, Anna-Leigh AL; Li, Minghui M; Goncearenco, Alexander A; Panchenko, Anna R AR
Publication Date: 2019-04

Variant appearance in text: EGFR: V765G
PubMed Link: 31034466
Variant Present in the following documents:
  • pcbi.1006981.s010.xlsx, sheet 1
View BVdb publication page



Inducing Oncoprotein Degradation to Improve Targeted Cancer Therapy.

Neoplasia (New York, N.Y.)
Ray, Dipankar D; Cuneo, Kyle C KC; Rehemtulla, Alnawaz A; Lawrence, Theodore S TS; Nyati, Mukesh K MK
Publication Date: 2015-09

Variant appearance in text: EGFR: V765G
PubMed Link: 26476077
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Kinome-wide decoding of network-attacking mutations rewiring cancer signaling.

Cell
Creixell, Pau P; Schoof, Erwin M EM; Simpson, Craig D CD; Longden, James J; Miller, Chad J CJ; Lou, Hua Jane HJ; Perryman, Lara L; Cox, Thomas R TR; Zivanovic, Nevena N; Palmeri, Antonio A; Wesolowska-Andersen, Agata A; Helmer-Citterich, Manuela M; Ferkinghoff-Borg, Jesper J; Itamochi, Hiroaki H; Bodenmiller, Bernd B; Erler, Janine T JT; Turk, Benjamin E BE; Linding, Rune R
Publication Date: 2015-09-24

Variant appearance in text: EGFR: V765G
PubMed Link: 26388441
Variant Present in the following documents:
  • mmc4.xlsx, sheet 1
View BVdb publication page



Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer.

Drug Resistance Updates : Reviews And Commentaries In Antimicrobial And Anticancer Chemotherapy
Mehra, Ranee R; Serebriiskii, Ilya G IG; Dunbrack, Roland L RL; Robinson, Matthew K MK; Burtness, Barbara B; Golemis, Erica A EA
Publication Date: 2011-12

Variant appearance in text: EGFR: V765G
PubMed Link: 21920801
Variant Present in the following documents:
  • Main text
View BVdb publication page